Basit öğe kaydını göster

dc.contributor.authorAksu, Tolga
dc.contributor.authorSOYSAL, ALİ UĞUR
dc.contributor.authorLyan, Evgeny
dc.contributor.authorEitel, Charlotte
dc.contributor.authorSaygi, Serkan
dc.contributor.authorTuran, Oguzhan Ekrem
dc.contributor.authorHegeer, Christian Hendrik
dc.contributor.authorTilz, Roland Richard
dc.contributor.authorDing, Wern Yew
dc.contributor.authorGupta, Dhiraj
dc.contributor.authorYALIN, KIVANÇ
dc.contributor.authorİKİTİMUR, BARIŞ
dc.contributor.authorÖZCAN, EMİN EVREN
dc.date.accessioned2022-07-04T14:09:02Z
dc.date.available2022-07-04T14:09:02Z
dc.identifier.citationYALIN K., İKİTİMUR B., Aksu T., ÖZCAN E. E. , Ding W. Y. , SOYSAL A. U. , Lyan E., Eitel C., Saygi S., Turan O. E. , et al., "Catheter Ablation for Atrial Fibrillation in Patients <= 30 Years of Age", AMERICAN JOURNAL OF CARDIOLOGY, cilt.166, ss.53-57, 2022
dc.identifier.issn0002-9149
dc.identifier.otherav_6aa10bfb-9f94-40ac-a03a-8f1998bbe8a6
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/183160
dc.identifier.urihttps://doi.org/10.1016/j.amjcard.2021.11.020
dc.description.abstractPulmonary vein (PV) automaticity is an established trigger for paroxysmal atrial fibrillation (PAF), making PV isolation (PVI) the cornerstone of catheter ablation. However, data on triggers for atrial fibrillation (AF) and catheter ablation strategy in very young patients aged 30 seconds after a 3-month blanking period. A total of 2 patients with atrioventricular nodal reentrant tachycardia, 1 with left atrial appendage tachycardia, experienced AF recurrence within the first 3 months and received PVI. After the 3-month blanking period, during a median follow-up of 17.0 +/- 10.1 months, 44 of 51 patients (86.2%) were free of ATA recurrence. In the PVI group, 33 of 39 patients (84.6%) experienced no ATA recurrence. In conclusion, SVT substrate is identified in around a quarter of young adult patients with history of AF, and targeted ablation without PVI may be sufficient in the majority of these patients. PVI is needed in the majority and is safe and effective in this population. (C) 2021 Published by Elsevier Inc.
dc.language.isoeng
dc.subjectHealth Sciences
dc.subjectCARDIAC ve CARDIOVASCULAR SİSTEMLER
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectKardiyoloji
dc.subjectCardiology and Cardiovascular Medicine
dc.titleCatheter Ablation for Atrial Fibrillation in Patients <= 30 Years of Age
dc.typeMakale
dc.relation.journalAMERICAN JOURNAL OF CARDIOLOGY
dc.contributor.departmentİstanbul Üniversitesi-Cerrahpaşa , Cerrahpaşa Tıp Fakültesi , Dahili Tıp Bilimleri Bölümü
dc.identifier.volume166
dc.identifier.startpage53
dc.identifier.endpage57
dc.contributor.firstauthorID3403168


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster